InterCure Ltd. (INCR)
NASDAQ: INCR · IEX Real-Time Price · USD
2.710
+0.180 (7.11%)
At close: Mar 28, 2024, 4:00 PM
2.730
+0.020 (0.74%)
After-hours: Mar 28, 2024, 7:38 PM EDT

InterCure Income Statement

Millions ILS. Fiscal year is Jan - Dec.
Year 20222021202020192018
Revenue
388.68219.6865.048.930
Revenue Growth (YoY)
76.93%237.78%628.60%--
Cost of Revenue
233.6128.5533.067.450
Gross Profit
155.0891.1331.981.480
Selling, General & Admin
92.6250.4217.0314.779.81
Research & Development
0.631.241.581.710
Other Operating Expenses
9.088.3247.247.380.58
Operating Expenses
102.3359.9865.8163.8610.39
Operating Income
52.7631.16-33.84-62.38-10.39
Interest Expense / Income
14.969.580.533.292.09
Other Expense / Income
-4.975.445.13-59.1-25.28
Pretax Income
42.7716.13-39.5-6.5712.8
Income Tax
0.0911.44-2.27-0.670
Net Income
42.684.69-37.23-5.8912.8
Net Income Growth
810.00%----
Shares Outstanding (Basic)
454343--
Shares Change
5.64%----
EPS (Basic)
0.990.12-1.42-0.25-0.71
EPS (Diluted)
0.990.11-1.42-0.25-0.71
EPS Growth
800.00%----
Free Cash Flow
31.5316.11-12.95-39.71-1.58
Free Cash Flow Per Share
0.700.38-0.30--
Gross Margin
39.90%41.48%49.17%16.57%-
Operating Margin
13.57%14.18%-52.03%-698.82%-
Profit Margin
10.98%2.13%-57.25%-66.02%-
Free Cash Flow Margin
8.11%7.33%-19.90%-444.91%-
Effective Tax Rate
0.22%70.93%---
EBITDA
57.7325.71-38.97-3.2714.89
EBITDA Margin
14.85%11.70%-59.92%-36.68%-
EBIT
57.7325.71-38.97-3.2714.89
EBIT Margin
14.85%11.70%-59.92%-36.68%-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).